- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Göttingen, Georg-August Universität, Dissertation, 2018
- Keyword
-
Genes
- Event
-
Veröffentlichung
- (where)
-
Göttingen
- (who)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (when)
-
2018
- Creator
-
Sriraman, Anusha
- Contributor
- Handle
-
11858/00-1735-0000-002E-E4AB-3
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-002E-E4AB-3-6
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sriraman, Anusha
- Dobbelstein, Matthias
- Johnsen, Steven A.
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Time of origin
- 2018
Other Objects (12)
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Targeting tumor suppressor p53 for organ fibrosis therapy
p73ΔN antagonist to the tumor suppressor p53 and independent regulator of transcription
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
p53 suppressor gene
Evolution of the p53-MDM2 pathway
MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
Small-Molecule Inhibitors of p53-MDM2 interactions
Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Targeting tumor suppressor p53 for organ fibrosis therapy
p73ΔN antagonist to the tumor suppressor p53 and independent regulator of transcription
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
p53 suppressor gene
Evolution of the p53-MDM2 pathway
MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
Small-Molecule Inhibitors of p53-MDM2 interactions
Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
Targeting tumor suppressor p53 for organ fibrosis therapy
p73ΔN antagonist to the tumor suppressor p53 and independent regulator of transcription
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
Targeting the p53-MDM2 and p53-MDMX interaction as a therapeutic strategy for anticancer treatment
A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
p53 suppressor gene
Evolution of the p53-MDM2 pathway
MDM2 Is Essential to Maintain the Homeostasis of Epithelial Cells by Targeting p53
RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
Small-Molecule Inhibitors of p53-MDM2 interactions